CCSD Code 0593B: Plasma Guanidinoacetate (GUAP) Blood billing guide

Key Takeaways

CCSD Code 0593B is the UK private healthcare billing code for Plasma Guanidinoacetate (GUAP) Blood testing, effective from 17 April 2023.

0593B and 0593U are distinct codes: 0593B is for a blood sample, 0593U is for a urine sample. Using the wrong code will result in claim rejection.

Reimbursement fees for 0593B are set by each insurer individually. CCSD defines the code; Bupa, AXA Health, Aviva, Vitality, and others set their own rates.

Pabau’s claims management software helps UK private practices submit CCSD diagnostic codes accurately and track insurer responses in one place.

CCSD Code 0593B: Definition and clinical context

CCSD Code 0593B covers the Plasma Guanidinoacetate (GUAP) Blood test, a specialist metabolic assay used to investigate suspected creatine deficiency syndromes and inborn errors of metabolism. The code was added to the CCSD Schedule of Diagnostic Tests with an effective date of 17 April 2023, meaning claims submitted before that date are invalid under this code.

Guanidinoacetate is a precursor molecule in the creatine biosynthesis pathway. When the enzyme guanidinoacetate methyltransferase (GAMT) is deficient, guanidinoacetate accumulates in the blood and urine.

Measuring plasma levels helps clinicians distinguish between GAMT deficiency and related metabolic disorders, including arginine:glycine amidinotransferase (AGAT) deficiency. GUAP testing is specialist territory, typically requested by metabolic medicine physicians or clinical geneticists rather than as a routine diagnostic screen.

For billing staff at UK private practices, the key point is that 0593B is a diagnostic service charge, not a procedure code. The CCSD FAQs page confirms this distinction: diagnostic codes do not sit in your procedure code table.

Procedure codes, such as 0049B, follow the CCSD Schedule of Procedures instead and are billed under a separate reference table. Diagnostic codes like 0593B are billed separately as pathology or laboratory charges alongside the relevant consultation or referral episode.

When is the GUAP blood test ordered?

Clinicians order the GUAP blood test when a patient presents with symptoms consistent with a creatine deficiency syndrome. These syndromes are rare inherited metabolic conditions, so testing is almost always initiated by a specialist rather than a GP or family physician in general practice.

Common clinical indications include:

• Unexplained intellectual disability or developmental regression
• Drug-resistant epilepsy with no structural cause identified
• Speech and language delay in the absence of a confirmed diagnosis
• Movement disorders or hypotonia in children
• Abnormal creatine or creatinine ratios on prior metabolic screening

Practices managing patients under metabolic medicine, pediatric neurology, or clinical genetics pathways are most likely to encounter this code.

If your practice provides private metabolic screening services, including for longevity and integrative medicine, confirm with your clinical lead whether GUAP testing falls within your service menu. For guidance on managing specialist referrals in private practice, see our guide on moving from the NHS.

0593B versus 0593U: blood versus urine

This is the most common coding error for guanidinoacetate testing. Two codes exist:

0593B took effect on 17 April 2023. 0593U followed later, effective 8 August 2024 under CCSD Bulletin 092, so the two codes do not share an effective date. In clinical practice, a metabolic specialist may still request both a blood and a urine sample as part of the same diagnostic episode.

When that happens, bill both 0593B and 0593U separately on the same claim. Do not combine them under a single code or attempt to use one code to cover both sample types. Insurers cross-reference sample type against the narrative, and a mismatch is a direct route to claim rejection.

Accurate documentation of the sample type in the patient record is therefore essential before submission. Pabau’s digital forms allow practices to capture structured diagnostic request information at the point of care, so the sample type is recorded and retrievable at billing time.

Insurer coverage and reimbursement for CCSD Code 0593B

CCSD sets the code narrative and structure. Individual UK private health insurers set their own reimbursement rates for each code, and not every insurer adopts every CCSD code onto their schedule at the same time. Before submitting a claim under 0593B, confirm with the relevant insurer that this code is active on their current schedule.

The major UK private health insurers that use CCSD diagnostic codes include:

Fees for specialist metabolic diagnostic tests vary considerably by insurer. Because 0593B is a niche code added relatively recently, in April 2023, some smaller insurers may not yet have an explicit rate for it. In that case, contact the insurer’s provider relations team directly before submitting.

Submitting a claim for a code that is not on the insurer’s active schedule is a common source of avoidable rejections. For a full overview of how Bupa processes CCSD diagnostic codes, see our Bupa CCSD codes guide.

How to bill CCSD Code 0593B correctly

Billing errors for diagnostic codes are usually procedural rather than clinical. The following steps reduce the risk of rejection when submitting 0593B claims.

Confirm prior authorization

Most UK private health insurers require prior authorization for specialist diagnostic tests. Check whether the patient’s insurer requires a pre-authorization reference number before the laboratory request is raised.

Submitting a claim without a valid authorization code, when one is required, results in automatic rejection regardless of clinical accuracy. The same requirement applies to other specialist assays, such as CCSD codes 0230B and 0046B.

The authorization request should specify the CCSD code being requested (0593B and/or 0593U), the requesting clinician’s name and recognition number, and the ICD or clinical indication if required by the insurer.

For private GP and specialist practices managing the prior authorization process in-house, structured patient records that capture the authorization reference alongside the diagnostic request save significant time at claim submission.

Assign the correct code and sample type

Use 0593B for a blood (plasma) sample. Use 0593U for a urine sample. If both were collected as part of the same episode, submit both codes on separate lines. Verify the laboratory report confirms the sample type before populating the claim form.

Reference the CCSD Technical Guide for submission rules

The CCSD Technical Guide (October 2025) sets out the coding conventions and business rules that apply to all diagnostic codes, including 0593B. Key rules for diagnostic codes include:

• They are billed separately from procedure codes
• They should not be combined with CCSD procedure codes in a way that implies unbundling
• The code narrative must match the test actually performed

Submit via the insurer’s preferred channel

Bupa accepts electronic submissions via their provider portal. Other insurers may require paper or PDF invoicing. Check the current submission requirements for each insurer before sending. Using the wrong submission channel does not automatically invalidate the claim, but it creates delays and increases the risk of the claim being processed under an incorrect code.

UK private practices handling volume CCSD billing benefit from claims management software that centralizes insurer submissions, tracks authorization references, and flags incomplete claims before they go out. For practices managing compliance across multiple specialties, see our overview of physiotherapy compliance requirements for UK private practices.

Submit CCSD claims without the rework

Pabau helps UK private practices manage CCSD diagnostic code submissions, track insurer authorizations, and maintain the patient records that support accurate billing. See how it works for your practice.

Book a demo

Related CCSD diagnostic codes

CCSD Code 0593B was introduced alongside a group of new diagnostic codes in the April 2023 schedule update. Several of these are clinically adjacent and may appear on the same claim or patient episode.

When a patient episode involves both metabolic and endocrine investigations, it is possible for 0593B and 0594B to appear on the same invoice. Each should be itemized separately. Do not bundle multiple diagnostic codes into a single line entry, as insurers require individual code-level visibility to process payment and verify clinical necessity.

If your practice handles metabolic health or integrative medicine services, tracking which diagnostic codes apply to which patient pathways matters for billing accuracy and audit readiness. Pabau’s measurements and tracking tools support structured recording of laboratory results alongside diagnostic code references in the patient record.

For a broader view of private healthcare fee structures, our Bupa procedure codes guide covers how Bupa structures reimbursement across its schedule.

Documentation requirements

UK private health insurers can request supporting clinical documentation when auditing diagnostic claims. For a specialist test like GUAP testing, the following records should be in place before submission:

• A clear clinical indication documented in the patient record, explaining why GUAP testing was clinically necessary
• The requesting clinician’s name, specialty, and insurer recognition number
• The laboratory report confirming the sample type (blood or urine) and the result
• The prior authorization reference number, if one was obtained
• A copy of the diagnostic invoice showing the CCSD code, narrative, and fee claimed

Insurers do not require you to justify clinical decisions on every claim. But when an audit occurs, missing documentation is the fastest route to retrospective disallowance of fees. Good record-keeping is as much a billing control as it is a clinical one.

For practices structuring documentation workflows for private practice compliance, our guide to UK GDPR compliance checklist covers data retention obligations that apply alongside insurer record-keeping requirements.

Practices handling high-volume private billing also benefit from features that save time, with structured workflows that link the diagnostic request, the laboratory result, and the insurance claim in one auditable trail.

Conclusion

CCSD Code 0593B is straightforward once the fundamentals are in place:

• The right sample type
• The correct companion code where applicable
• A prior authorization reference
• Documentation that would withstand an insurer audit

The most common error is conflating 0593B (blood) with 0593U (urine). Build a quick verification step into your submission workflow and that risk disappears.

For UK private practices managing CCSD diagnostic billing at volume, Pabau brings together code submission, authorization tracking, and patient record documentation in one place. To see how it handles CCSD diagnostic workflows, book a demo.

Continue your research

List Item #1

List Item #2

Frequently asked questions